Growth properties of cardiac stem cells are a novel biomarker of patients’ outcome after coronary bypass surgery
In this study, the authors identify a number of markers in cardiac stem cells obtained from 38 patients undergoing coronary artery bypass grafting which appear to predict positive myocardial remodelling at 12 months following surgery
0
0 comments